PKM2/PDK1 dual-targeted shikonin derivatives restore the sensitivity of EGFR-mutated NSCLC cells to gefitinib by remodeling glucose metabolism - Concepedia

Concepedia

Publication | Open Access

PKM2/PDK1 dual-targeted shikonin derivatives restore the sensitivity of EGFR-mutated NSCLC cells to gefitinib by remodeling glucose metabolism

DOI Full Paper Access

37

Citations

23

References

2023

Year

Hongyan Lin, Hongwei Han, Minkai Yang, Zhongling Wen, Qingqing Chen, Yudi Ma, Xuan Wang, Changyi Wang, Tongming Yin, Xiaoming Wang,

European Journal of Medicinal Chemistry

Signaling PathwayGlucose MetabolismMedicineReceptor Tyrosine KinaseCellular BiochemistryPharmacologyCell BiologyCell SignalingNovel TherapyTumor BiologyEgfr-mutated Nsclc Cells

References

	Year	Citations

Page 1

Page 1